Mosapride citrate dihydrate is a selective 5-HT4 receptor agonist used as a gastroprokinetic agent to enhance gastric and duodenal motility. It is clinically indicated for the treatment of functional dyspepsia, gastroesophageal reflux disease (GERD), diabetic gastroparesis, and gastric motility disorders in patients following partial gastrectomy. It works by stimulating 5-HT4 receptors in the myenteric plexus, promoting acetylcholine release and thereby improving gastrointestinal motility without affecting gastric acid secretion.